# Shunzaburo Iwatsuki

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/shunzaburo-iwatsuki/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,958 |
| Field | Organ Transplantation Techniques and Outcomes |
| h-index | 76 |
| i10-index | 175 |
| Last Known Institution | University of Pittsburgh |
| OpenAlex ID | https://openalex.org/A5113681498 |
| Works | 237 |

## Researcher papers

- [REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY](https://scholariq.org/papers/reversibility-of-lymphomas-and-lymphoproliferative-lesions-developing-under/)
- [Venous Bypass in Clinical Liver Transplantation](https://scholariq.org/papers/venous-bypass-in-clinical-liver-transplantation/)
- [HEART-LIVER TRANSPLANTATION IN A PATIENT WITH FAMILIAL HYPERCHOLESTEROLAEMIA](https://scholariq.org/papers/heart-liver-transplantation-in-a-patient-with-familial-hypercholesterolaemia/)
- [A Flexible Procedure for Multiple Cadaveric Organ Procurement](https://scholariq.org/papers/a-flexible-procedure-for-multiple-cadaveric-organ-procurement/)

## Researcher topics

- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)

## Researcher university

- [University of Pittsburgh](https://scholariq.org/institutions/university-of-pittsburgh/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.